Eliana Clark serves as Executive at Intellia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Eliana Clark has executed 14 insider transactions totaling $481.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 1, 2024 involved selling 405 shares valued at $9.3K.
Eliana Clark currently holds 71,470 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eliana Clark has been a net seller of NTLA stock. They have purchased $0 and sold $481.1K worth of shares.
Eliana Clark's most recent insider trade was on Jul 1, 2024, when they sold 405 shares at $22.93 per share.
Get notified when new Form 4 filings are submitted
| $32.99 |
| Discretionary |
| Mar 1, 2024 | NTLA | $0 | Award | 31,230 | $N/A | Discretionary |
| Jan 3, 2024 | NTLA | $126.7K | Sale | 4,301 | $29.46 | Discretionary |
| Jan 3, 2024 | NTLA | $9.2K | Sale | 307 | $30.12 | Discretionary |
| Jul 3, 2023 | NTLA | $14.6K | Sale | 360 | $40.51 | Discretionary |
| Jun 20, 2023 | NTLA | $225.0K | Sale | 5,000 | $45.00 | Planned |
| Jun 20, 2023 | NTLA | $61.4K | Option Exercise | 5,000 | $12.27 | Planned |
| Mar 1, 2023 | NTLA | $0 | Award | 24,539 | $N/A | Discretionary |
| Mar 1, 2023 | NTLA | $0 | Award | 6,134 | $N/A | Discretionary |
| Jan 4, 2023 | NTLA | $63.0K | Sale | 1,692 | $37.21 | Discretionary |
| Jan 3, 2023 | NTLA | $8.0K | Sale | 231 | $34.48 | Discretionary |
| Jul 1, 2022 | NTLA | $5.4K | Sale | 105 | $51.74 | Discretionary |
| Mar 1, 2022 | NTLA | $0 | Award | 10,527 | $N/A | Discretionary |